Predicting Longitudinal Cognitive Decline and Alzheimer’s Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers

The increasing burden of Alzheimer’s disease (AD) emphasizes the need for effective diagnostic and therapeutic strategies. Despite available treatments targeting amyloid beta (Aβ) plaques, disease-modifying therapies remain elusive. Early detection of mild cognitive impairment (MCI) patients at risk...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Min-Koo Park, Jinhyun Ahn, Young-Ju Kim, Ji-Won Lee, Jeong-Chan Lee, Sung-Joo Hwang, Keun-Cheol Kim
Format:	Article
Language:	English
Published:	MDPI AG 2024-06-01
Subjects:	plasma biomarker neuropsychological measure linear mixed model cognitive decline MCI-to-AD conversion
Online Access:	https://www.mdpi.com/2073-4409/13/13/1085